Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board
Progyny (NASDAQ: PGNY), a leading women's health and family building solutions provider, has strengthened its Medical Advisory Board with two distinguished appointments. Dr. Gloria Richard-Davis from Morehouse School of Medicine and Dr. Whitney Booker from Columbia University join the board, bringing extensive expertise in women's health and reproductive medicine.
Dr. Richard-Davis is double-board certified in OB-GYN and Reproductive Endocrinology and Infertility, with significant experience in menopause care and health equity. Dr. Booker, double-board certified in OB-GYN and Maternal-Fetal Medicine, specializes in high-risk maternal care and prenatal fetal diagnosis, with NIH-funded research focusing on hypertension and cardiovascular disease in pregnancy.
Progyny (NASDAQ: PGNY), un'azienda leader nelle soluzioni per la salute femminile e la costruzione della famiglia, ha rafforzato il suo Medical Advisory Board con due nomine di rilievo. La dottoressa Gloria Richard-Davis della Morehouse School of Medicine e la dottoressa Whitney Booker della Columbia University si uniscono al consiglio, apportando una vasta esperienza nella salute delle donne e nella medicina riproduttiva.
La dottoressa Richard-Davis è doppia certificata in Ostetricia-Ginecologia e Endocrinologia Riproduttiva e Infertilità, con una significativa esperienza nella cura della menopausa e nell'equità sanitaria. La dottoressa Booker, anch'essa doppia certificata in Ostetricia-Ginecologia e Medicina Materno-Fetale, è specializzata nella cura materna ad alto rischio e nella diagnosi prenatale fetale, con ricerche finanziate dal NIH focalizzate sull'ipertensione e le malattie cardiovascolari in gravidanza.
Progyny (NASDAQ: PGNY), un proveedor líder en soluciones para la salud de la mujer y la formación de familias, ha fortalecido su Junta Asesora Médica con dos nombramientos destacados. La Dra. Gloria Richard-Davis de la Morehouse School of Medicine y la Dra. Whitney Booker de la Universidad de Columbia se unen a la junta, aportando una amplia experiencia en salud femenina y medicina reproductiva.
La Dra. Richard-Davis cuenta con doble certificación en Obstetricia-Ginecología y Endocrinología Reproductiva e Infertilidad, con una experiencia significativa en el cuidado de la menopausia y la equidad en salud. La Dra. Booker, también doble certificada en Obstetricia-Ginecología y Medicina Materno-Fetal, se especializa en atención materna de alto riesgo y diagnóstico prenatal fetal, con investigaciones financiadas por el NIH centradas en hipertensión y enfermedades cardiovasculares durante el embarazo.
Progyny (NASDAQ: PGNY)는 여성 건강 및 가족 형성 솔루션 분야의 선도 기업으로, 두 명의 저명한 전문가를 의료 자문 위원회에 새로 임명하며 위원회를 강화했습니다. Morehouse School of Medicine의 글로리아 리처드-데이비스 박사와 Columbia University의 휘트니 부커 박사가 위원회에 합류하여 여성 건강 및 생식 의학 분야에서 풍부한 전문 지식을 제공합니다.
리처드-데이비스 박사는 산부인과 및 생식내분비학 및 불임 분야에서 이중 인증을 받았으며, 폐경기 관리와 건강 형평성에 대한 풍부한 경험을 가지고 있습니다. 부커 박사는 산부인과 및 모체-태아 의학 분야에서 이중 인증을 받았으며, 고위험 산모 관리와 태아 산전 진단을 전문으로 하며, NIH 지원 연구로 임신 중 고혈압 및 심혈관 질환에 초점을 맞추고 있습니다.
Progyny (NASDAQ : PGNY), un fournisseur de premier plan de solutions pour la santé des femmes et la création de familles, a renforcé son conseil consultatif médical avec deux nominations distinguées. La Dre Gloria Richard-Davis de la Morehouse School of Medicine et la Dre Whitney Booker de l'Université de Columbia rejoignent le conseil, apportant une expertise approfondie en santé des femmes et en médecine reproductive.
La Dre Richard-Davis est doublement certifiée en obstétrique-gynécologie et en endocrinologie reproductive et infertilité, avec une expérience significative dans les soins de la ménopause et l'équité en santé. La Dre Booker, également doublement certifiée en obstétrique-gynécologie et médecine materno-fœtale, se spécialise dans les soins maternels à haut risque et le diagnostic prénatal fœtal, avec des recherches financées par le NIH axées sur l'hypertension et les maladies cardiovasculaires pendant la grossesse.
Progyny (NASDAQ: PGNY), ein führender Anbieter von Lösungen für Frauengesundheit und Familienaufbau, hat seinen Medizinischen Beirat mit zwei herausragenden Ernennungen verstärkt. Dr. Gloria Richard-Davis von der Morehouse School of Medicine und Dr. Whitney Booker von der Columbia University treten dem Gremium bei und bringen umfangreiche Expertise in Frauengesundheit und reproduktiver Medizin mit.
Dr. Richard-Davis ist doppelt zertifiziert in Gynäkologie und Geburtshilfe sowie Reproduktionsendokrinologie und Unfruchtbarkeit und verfügt über umfassende Erfahrung in der Menopauseversorgung und Gesundheitsgerechtigkeit. Dr. Booker, ebenfalls doppelt zertifiziert in Gynäkologie und Geburtshilfe sowie Maternal-Fetal-Medizin, spezialisiert sich auf Risikoschwangerschaften und pränatale Fetaldiagnostik, mit NIH-finanzierter Forschung zu Bluthochdruck und Herz-Kreislauf-Erkrankungen in der Schwangerschaft.
- None.
- None.
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists (FACOG), and a Menopause Society Certified Practitioner (MSCP) – and Columbia University’s Dr. Whitney Booker – a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine – to its Medical Advisory Board.
“As Progyny continues to be at the forefront of women’s health, we are proud to welcome two deeply respected clinical leaders whose unique training and lived experience will bring critical insights to our work,” said Dr. Janet Choi, Chief Medical Officer at Progyny. “Dr. Richard-Davis and Dr. Booker have spent their careers advancing care, health equity, and research in fertility, maternal health, and beyond – their individual expertise will complement our board as we continue to expand across the women’s health spectrum.”
Dr. Gloria Richard-Davis is a nationally recognized leader in women’s health and reproductive medicine, with deep expertise in advancing health equity across academic, clinical, and organizational settings. She is a member of The Endocrine Society, Society of Reproductive Endocrinologists, American Medical Association, among others. She completed her OB-GYN residency at Madigan Army Medical Center and advanced training in fertility and reproductive endocrinology. Her academic career includes leadership roles at Tulane University, Meharry Medical College, and the University of Arkansas for Medical Sciences. She has also held multiple leadership roles within the Menopause Society (formerly North American Menopause Society) and the American Society for Reproductive Medicine (ASRM) and is a recipient of the ASRM Gold Humanitarian Practitioner Award.
“I’ve dedicated my career to advancing access and education in women’s health, particularly in areas like menopause that have long been overlooked,” said Dr. Richard-Davis. “Progyny is raising the bar for how fertility and menopause benefits can address whole-person care, and I’m proud to be part of this team changing the lives of so many individuals.”
Dr. Whitney A. Booker is a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine, nationally recognized for her work in prenatal fetal diagnosis and high-risk maternal care. She is an expert in advanced ultrasound imaging, prenatal genetic testing, and managing pregnancies complicated by rare maternal conditions. Dr. Booker is also a physician-scientist, with NIH and university grant funding supporting her research into hypertension and cardiovascular disease in pregnancy. She brings expertise in treating pregnancies conceived through IVF and in advanced maternal age.
“Progyny is changing the way care is delivered across the full parenting journey by partnering with trained specialists and delivering high-touch, personalized support to each of its members,” said Dr. Booker. “I see firsthand the impact of comprehensive support for high-risk pregnancies, and I look forward to bringing my unique insights in this area to Progyny’s Medical Advisory Board to help meet the needs of these women and families.”
For more information on Progyny visit www.progyny.com and for more information on its Medical Advisory Board visit www.progyny.com/medical-advisory-board/.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Media:
Alexis Ford
media@progyny.com
Investors:
James Hart
investors@progyny.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0f685a60-ac4b-4dd8-ac77-8ae2d0822fa9
FAQ
Who are the new members of Progyny's Medical Advisory Board in 2025?
What are Dr. Gloria Richard-Davis's qualifications at Progyny (PGNY)?
What is Dr. Whitney Booker's specialization at Progyny (PGNY)?
How will these appointments benefit Progyny's (PGNY) services?
